Explore Thiopental, a potent barbiturate anesthetic. Learn about its rapid-onset action, medical uses in anesthesia and seizure control, dosage, potential side effects, and vital safety information.
Browse our catalog for available pharmaceutical products and competitive pricing.
Thiopental is a rapid-onset, short-acting barbiturate general anesthetic. It is a derivative of barbituric acid and is primarily used for the induction of general anesthesia or for short surgical procedures. Discovered in 1930 and first synthesized in 1932 by Ernest H. Volwiler and Donalee L. Tabern, it quickly gained prominence in medical practice due to its effectiveness in inducing a rapid, smooth loss of consciousness. Its introduction revolutionized anesthetic practice, offering a significant improvement over earlier, slower-acting agents.
Chemically, Thiopental is the sulfur analogue of pentobarbital, where an oxygen atom in the urea moiety is replaced by a sulfur atom. This structural modification accounts for its increased lipid solubility, which is crucial for its rapid penetration of the blood-brain barrier and consequently, its fast onset of action. As a central nervous system depressant, it belongs to the class of barbiturates, a group of drugs known for their sedative, hypnotic, anxiolytic, and anticonvulsant properties.
The official ATC (Anatomical Therapeutic Chemical) code for Thiopental is N01AF03, categorizing it under "General Anesthetics" and specifically "Barbiturates." Despite its widespread historical use, its application has somewhat declined in general anesthesia due to the development of newer agents with more favorable pharmacokinetic and pharmacodynamic profiles and fewer side effects. However, Thiopental remains an important drug in specific clinical scenarios, particularly for rapid sequence induction and neuroprotection.
The primary mechanism of action for Thiopental involves its interaction with the gamma-aminobutyric acid (GABA) type A (GABA-A) receptor complex, which is the major inhibitory neurotransmitter system in the central nervous system (CNS). Thiopental acts as a positive allosteric modulator of the GABA-A receptor. Unlike benzodiazepines, which increase the frequency of chloride channel opening, barbiturates like Thiopental increase the duration of chloride channel opening when GABA binds to the receptor. This prolonged influx of chloride ions into the neuron leads to hyperpolarization of the neuronal membrane, making it less excitable and thus inhibiting neuronal activity.
Beyond its primary effect on GABA-A receptors, Thiopental also exerts other CNS effects. At higher concentrations, it can directly activate GABA-A receptors even in the absence of GABA, further amplifying its inhibitory actions. Additionally, Thiopental has been shown to inhibit excitatory neurotransmitter systems, such as those mediated by AMPA and kainate receptors, and to block sodium channels, which contributes to its anticonvulsant properties. These combined actions result in profound CNS depression, leading to sedation, hypnosis, and anesthesia. Its high lipid solubility facilitates rapid distribution into the brain, explaining its quick onset of action, while redistribution to other tissues accounts for its short duration of action following a single bolus dose.
Thiopental is a versatile barbiturate with several important medical applications, primarily centered around its potent central nervous system depressant effects. Its rapid onset and short duration of action make it particularly useful in acute settings where swift control over consciousness or seizure activity is required. While newer agents have emerged, Thiopental maintains its role in specific clinical situations due to its established efficacy and neuroprotective properties.
The dosage of Thiopental is highly individualized and depends on several factors, including the patient's age, weight, physical status, the specific indication for use, and the concomitant administration of other medications. It is crucial for administration to be carried out by trained medical professionals in a controlled clinical environment, with immediate access to resuscitation equipment. Thiopental is typically administered intravenously.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Anesthesia Induction | 3-5 mg/kg body weight | Single bolus | Intravenous (IV) |
| Status Epilepticus | 1.5-5 mg/kg initial bolus, then 1-3 mg/kg/hr infusion | As needed, continuous infusion | Intravenous (IV) |
| Increased Intracranial Pressure (ICP) | 1.5-5 mg/kg initial bolus, then 0.5-2 mg/kg/hr infusion | As needed, continuous infusion | Intravenous (IV) |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition, and may require titration to achieve the desired clinical effect while minimizing adverse reactions. Close monitoring of vital signs and neurological status is essential during Thiopental administration.
Like all potent medications, Thiopental is associated with a range of side effects, stemming from its widespread depressant effects on the central nervous system and other physiological systems. The incidence and severity of these effects are often dose-dependent and can be influenced by patient comorbidities and concurrent medications.
Thiopental can interact with a wide array of other medications, potentially altering its own effects or the effects of the co-administered drugs. These interactions can lead to either increased toxicity or reduced efficacy, making a thorough review of a patient's medication history critical before administering Thiopental. Care must be taken, especially with other CNS depressants.
The use of Thiopental is contraindicated in certain patient populations and clinical conditions due to the risk of severe adverse outcomes. Careful patient assessment and risk-benefit analysis are paramount before administration.
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication, or for any health concerns. The use of Thiopental requires specialized medical knowledge and administration in a controlled clinical setting.
No, Thiopental is not intended for long-term use. It is a short-acting anesthetic primarily used for induction of anesthesia or for short-term control of acute conditions like status epilepticus or elevated intracranial pressure. Prolonged administration can lead to significant accumulation in fatty tissues, resulting in a very long elimination half-life, prolonged sedation, and increased risk of severe adverse effects, particularly respiratory depression and cardiovascular instability. Its use is typically limited to acute, controlled settings.
Thiopental is administered intravenously, typically in a hospital or clinical setting, and is not taken orally with food. Its administration is independent of food intake. Patients receiving Thiopental are usually NPO (nil per os) or have restricted oral intake, especially if it's for anesthesia induction or a critical care scenario. Therefore, the concept of taking Thiopental with food does not apply.
Thiopental is not a medication that patients typically self-administer or take on a regular schedule at home. It is administered by healthcare professionals in a controlled environment. If you are a patient receiving Thiopental as part of a continuous infusion (e.g., for refractory status epilepticus or elevated ICP), healthcare providers are responsible for monitoring and adjusting the dosage. A "missed dose" scenario is highly unlikely in this context. Any concerns about your medication regimen should be immediately addressed with your treating physician or nursing staff.
Thiopental is a highly controlled pharmaceutical compound that requires a prescription and is administered exclusively by licensed medical professionals in a hospital or clinical setting. It is not available for purchase over-the-counter or from retail pharmacies for self-administration. Attempts to buy Thiopental outside of legitimate, licensed medical channels are illegal and extremely dangerous. Always obtain medications through proper legal and medical pathways under the guidance of a qualified healthcare provider.